XELOX Combined With Cadonilimab Versus XELOX as Neoadjuvant Treatment for Locally Advanced, pMMR Rectal Cancer

NCT05815303 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

92

Enrollment

OTHER

Sponsor class

Conditions

Rectal Cancer
MSS

Interventions

DRUG: Cadonilimab
DRUG: Oxaliplatin
DRUG: Capecitabine

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences